World Bulletin / News Desk
British scientists have identified biological markers in the blood which should help doctors match patients to the best type of treatment for depression.
The aim is to end the "trial and error" prescription of antidepressants, which is often the only way depressed patients can find the most effective treatment, said researchers regarding what they described as a small but promising study.
"The study shows that we could use a blood-based "test" to personalise the treatment of depression," said Carmine Pariante of King's College London's Institute of Psychiatry, who led the study. She and colleagues found that high levels of inflammation - which show up in biological markers in the blood - are part of the mechanism leading to depression, especially to particular forms of the condition that do not respond well to mild or low-dose antidepressants.
"If a patient had high levels of inflammation, they could immediately begin with a more intensive treatment programme, such as combining antidepressants or stepping up the doses," Pariante said.
A MAJOR PROBLEM
Major depression affects around 20 percent of people at some point in their lives. The World Health Organisation (WHO)predicts that by 2020, depression will rival heart disease as the health disorder with the highest global disease burden.
While there are many antidepressants on the market, including top sellers such as Prozac and Seroxat, it is widely accepted that many antidepressants work in only half of patients half of the time, and drugmakers are struggling to come up with a new generation of drugs in this field.
In the study published on Wednesday in the journal Neuropsychopharmacology, Pariante's team set out to try to identify two types of biomarkers - ones which could predict future response to antidepressants, called predictors, and others which are targeted by antidepressants and change over the course of treatment, called targets.
The researchers explained that in human cells, information from genes is transcribed into so-called messenger RNA, or mRNA, before it becomes visible as a physical or biochemical sign. So the team monitored the patients' mRNA before and after they were treated with one of two antidepressants - escitalopram or nortriptyline.
Escitalopram, sold under various brand names including Lexapro, Seroplex, Cipralex and made by generic drugmakers, is a serotonin reuptake inhibitor (SSRI).
Nortriptyline, sold under the brand names Sensoval, Aventyl and others, is an older type of antidepressant known as a tricyclic. They are both commonly prescribed as first line antidepressant treatments in Britain and other countries.
After 8 weeks of treatment, the researchers found that patients who were not getting any better were ones who had significantly higher levels of three inflammation markers before treatment started.
This suggests these three signals could be used to find patients who are least likely to respond to antidepressants, allowing doctors to consider a more tailored or "personalised" approach to treatment from the start, the researchers said.
"This is a small study, but the findings are promising," they said in a statement. "Personalised treatments for depression could help us avoid the current 'trial and error' way of prescribing antidepressant medication."
The London-based Environmental Investigation Agency (EIA) estimated that in 2013, at least 93 percent of logging in Mozambique was illegal -- and that most of the illicit timber ended up sold in China.
Erik Solheim told AFP in an interview on Monday that even if the United States withdraws, China and the European Union will step in and take the lead to implement the global agreement on reducing greenhouse gas emissions.
Polyethylene represents 40 percent of Europe's demand for plastic products, mostly in the form of packaging and shopping bags.
The High Court had demanded ministers come up with a plan to tackle illegal levels of nitrogen dioxide pollution, largely caused by diesel emissions, by 3:00 pm (1400 GMT) on Monday.
PEG-2S promises to tackle superbugs that threaten world health
The change affects grazing conditions for the 146,000 or so semi-domesticated reindeer in Norway who feed on lichen and moss under the snow.
The discovery of the giant shipworm, a species never before studied, marked the first time scientists had live specimens in hand, according to an article published this week in American journal Proceedings of the National Academy of Sciences.
As many as one in 45 children are diagnosed with autism spectrum disorder in the United States, according to a recent study by the US Centers for Disease Control and Prevention.
A full 1.6 billion people remain affected by NTDs -- more than 500 million of them children -- but that number is down from more than two billion in 2010, WHO said.
For the first time ever in modern history, a team of scientists Monday documented as what they're describing as large-scale river reorganization as a result of human-caused climate change.
In the next few hours he will receive a healthy kidney thanks to a pioneering system that has made Spain the world leader in organ transplants for the past 25 years.
Japan's corals, the northernmost in the world, could offer important data to bolster knowledge about marine life, as Australia's Great Barrier Reef faces a threat to its survival.
China is the world's largest consumer and producer of tobacco, and the industry provides the government with colossal sums.
During his time leading IAS, Mark Wainberg organised the 13th International AIDS conference in Durban, South Africa, and he also co-chaired the same conference in Toronto in 2006.
The UN's health agency said the epidemic had left more than 25,000 people sick, warning that number was likely to double by the end of June.
80 percent of countries acknowledge that their financing is still not enough to meet their nationally-set targets for increasing access to safe water and sanitation, it found.